|
Originally published In Press as doi:10.1074/jbc.M203762200 on July 11, 2002
J. Biol. Chem., Vol. 277, Issue 40, 37519-37526, October 4, 2002
Crystal Structure of the F87W/Y96F/V247L Mutant of Cytochrome
P-450cam with 1,3,5-Trichlorobenzene Bound and Further Protein
Engineering for the Oxidation of Pentachlorobenzene and
Hexachlorobenzene*,
Xuehui
Chen ,
Alexandra
Christopher§,
Jonathan P.
Jones§,
Stephen G.
Bell§,
Qing
Guo ,
Feng
Xu ,
Zihe
Rao ¶, and
Luet-Lok
Wong§
From the Laboratory of Structural Biology, Department
of Biological Science and Technology & Ministry of Education Laboratory
of Protein Science, Tsinghua University, Beijing 100084, China and the
§ Department of Chemistry, Inorganic Chemistry Laboratory,
University of Oxford, South Parks Road,
Oxford, OX1 3QR, United Kingdom
Received for publication, April 18, 2002, and in revised form, July 11, 2002
 |
ABSTRACT |
We reported previously that the
F87W/Y96F/V247L mutant of cytochrome P-450cam (CYP101) from
Pseudomonas putida catalyzed the rapid oxidation of lightly
chlorinated benzenes, but pentachlorobenzene oxidation was slow (Jones,
J. P., O'Hare, E. J., and Wong, L. L. (2001) Eur.
J. Biochem. 268, 1460-1467). In the present work, we
determined the crystal structure of this mutant with bound 1,3,5-trichlorobenzene. The substrate was bound to crystallographically independent CYP101 molecules in at least three different orientations, which were distinguished by the angle between the benzene ring and the
porphyrin, and one orientation contained an Fe-Cl interaction. In
another orientation, the substrate was almost parallel to the heme,
with a C-H bond closest to the iron. The enzyme/substrate contacts
suggested that the L244A mutation should promote the binding of
pentachlorobenzene and hexachlorobenzene by creating space to
accommodate the extra chlorines. The F87W/Y96F/L244A/V247L mutant thus
designed was found to oxidize pentachlorobenzene at a rate of
82.5 nmol (nmol CYP101) 1 min 1, 45 times faster than the F87W/Y96F/V247L parent mutant. The rate of
hexachlorobenzene oxidation was increased 200-fold, to 2.0 min 1. Both substrates are oxidized to pentachlorophenol,
which is degraded by micro-organisms. In principle, the
F87W/Y96F/L244A/V247L mutant could have applications in the
bioremediation of polychlorinated benzenes.
 |
INTRODUCTION |
The cytochrome P-450 enzymes are mixed function oxidases that
primarily catalyze the oxidation of C-H bonds in a great variety of
endogenous and exogenous organic compounds, ranging from small alkanes
to steroidal and polyaromatic compounds and very large molecules such
as cyclosporin (1, 2). These reactions are important in biosynthesis,
biochemistry, pharmacology, and clinical medicine. A great deal of
research effort has been directed at understanding the relationship
between structure, function, and reactivity (2) and to engineer these
enzymes for biotechnological applications (3-5).
Polychlorinated aromatic compounds are hazardous and recalcitrant
environmental contaminants and, as such, are classified as priority
pollutants by the environment agencies of the United States and Europe
(6, 7). The majority of the less chlorinated benzenes, biphenyls
(polychlorinated biphenyls), and dioxins can be degraded by a
consortium of micro-organisms (8-10). However, as the degree of
chlorination increases, the compounds become more inert, and the
heavily chlorinated homologues are partially degraded at slow rates or
not at all. For example, pentachlorobenzene (PeCB)1 and hexachlorobenzene
(HCB) are highly recalcitrant (11).
Aerobic micro-organisms degrade chlorinated aromatic
compounds via initial attack by nonheme iron dioxygenases to form the cis-dihydrodiol. After re-aromatization to chlorocatechols,
catechol 1,2-dioxygenases (another class of nonheme iron enzymes)
cleave the aromatic ring (7, 10). Both of these dioxygenases appear to
require certain ring positions to remain unsubstituted (12-14), and no
strictly aerobic organism capable of degrading PeCB, HCB, and the
heavily chlorinated polychlorinated biphenyls and dioxins has been
isolated. Instead, these compounds are degraded by much slower
reductive pathways (7).
Unlike the benzenes, polychlorinated phenols are readily mineralized by
micro-organisms (15). The degradation pathways for heavily chlorinated
phenols typically involve oxidation to chlorohydroquinones catalyzed by
flavin-dependent monooxygenases (16-19). The reactive chlorohydroquinones are then dehalogenated by hydrolytic or reductive mechanisms. We have proposed that chlorophenol degrading
micro-organisms could be genetically augmented with monooxygenase
enzymes that can convert chlorinated benzenes to the phenol derivatives
(20, 21). Provided that the introduced enzyme could oxidize the heavily chlorinated benzenes to the phenol derivatives at significant rates,
the novel micro-organisms thus generated could degrade all chlorinated
benzenes (Fig. 1).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
A scheme for the potential application of
cytochrome P-450 enzymes in the bioremediation of polychlorinated
benzenes.
|
|
We showed recently that the heme monooxygenase CYP101 from
Pseudomonas putida (22, 23) could be engineered to oxidize all of the lightly chlorinated benzenes with high activity and coupling
efficiency compared with the wild type enzyme (20, 21). The triple
mutant F87W/Y96F/V247L oxidized 1,3,5-trichlororbenzene (1,3,5-TCB)
with a catalytic turnover rate of 175 min 1 and 57%
coupling; this activity is more than sufficient for the application of
this mutant in the bioremediation of the recalcitrant 1,3,5-TCB. This
mutant also showed a fast NADH oxidation rate with PeCB as the
substrate, but the PeCB oxidation rate was slow because of extensive
uncoupling (21). Nevertheless, we were encouraged by the NADH turnover
rate because this indicated that the PeCB was bound within the CYP101
active site, although not in the correct orientation to suppress
uncoupling side reactions.
We report here our efforts to gain further insight into CYP101
substrate specificity and to improve the activity and coupling efficiency for the oxidation of PeCB and HCB by engineered CYP101 mutants. We determined the crystal structure of the F87W/Y96F/V247L mutant of CYP101 with 1,3,5-TCB bound within the active site. The
structure provided new information on CYP101 substrate recognition and
indicated an additional mutation that greatly increased the PeCB and
HCB oxidation activity.
 |
MATERIALS AND METHODS |
General--
Enzymes for molecular biology were from New England
Biolabs. Buffer components were from Anachem, and general reagents were from Sigma or Merck. NADH was from Roche Diagnostics. 1,3,5-TCB, PeCB,
HCB, and PCP were from Sigma. UV-visible spectra were recorded on a
Varian CARY 1E spectrophotometer equipped with a Peltier cell
temperature controller (± 0.1 °C). The HPLC analyses were performed
on a Gilson system.
Enzymes and Molecular Biology--
General DNA and
microbiological manipulations were carried out by standard methods
(24). The CYP101 enzyme and the physiological electron transfer
co-factor proteins putidaredoxin and putidaredoxin reductase were
expressed in Escherichia coli and purified following literature methods (25-27). The purified proteins were stored at 20 °C in buffers containing 50% glycerol. Immediately before use
in activity assays, glycerol was removed by gel filtration on a PD-10
column (Amersham Biosciences), eluting with 50 mM Tris, pH
7.4. Site-directed mutagenesis was carried out using the QuikChange kit
from Stratagene. All of the CYP101 enzymes described in this work also
contained the C334A mutation to prevent protein dimerization via
disulfide bond formation (28). For convenience, the C334A base mutant
is referred to as "wild type," and the Y96F/C334A double mutant is
referred to as Y96F, etc. The mutants Y96F, F87W/Y96F, and
F87W/Y96F/V247L had been prepared previously (21). The following oligonucleotides (and their reverse complements) were used on the
F87W/Y96F mutant gene to generate the new mutants (target codons
underlined): F87W/Y96F/L244A,
5'-AAGAGGATGTGTGGCGCGTTACTGGTCGGCGGC-3'; F87W/Y96F/V247A, 5'-TGTGGCCTGTTACTGGCGGGCGGCCTGGATACG-3';
and F87W/Y96F/L244A/V247L,
5'-AGGATGTGTGGCGCGTTACTGCTCGGCGGCCTGGAT-3'. The
mutants were identified and fully sequenced by automated DNA sequencing on an ABI 377XL Prism DNA sequencer by the DNA sequencing facility at the Department of Biochemistry, University of Oxford.
CYP101 Crystallization and Substrate Soaking
Experiments--
Crystals of the F87W/Y96F/V247L mutant were obtained
at 291 K by the hanging drop vapor diffusion method. Immediately prior to crystallization the mutant was further purified by size exclusion chromatography on a Superdex 75 (Amersham Biosciences) column (16 mm
inner diameter × 80 cm), eluting with 40 mM phosphate
buffer, pH 7.4, containing 1 mM camphor, 10 mM
-mercaptoethanol, and 200 mM KCl at a flow rate of 0.8 ml min 1. The protein was buffer exchanged into 100 mM cacodylate, pH 6.5, 200 mM KCl, and
concentrated to 8 mg ml 1 by ultrafiltration. A 1-µl
aliquot of this solution was mixed with 1 µl of 30% PEG8000 in
buffer A (100 mM cacodylate, 200 mM sodium
acetate) and suspended over 1 ml of 18-24% PEG8000 in buffer A. Diffraction quality crystals of CYP101 appeared within 24 h. The
crystals were transferred using a fiber loop and soaked in 100 mM MES buffer, pH 6.5, 100 mM sodium acetate,
100 mM KCl, 20% PEG8000, and 100 µM
1,3,5-TCB (added as a 100 mM stock in ethanol) for 5 days.
Data Collection and Structure Refinement--
Immediately prior
to data collection, the crystals were soaked in a cryoprotecting
solution consisting of 100 mM MES buffer, pH 6.5, 100 mM KCl, 100 mM sodium acetate, 20% glycerol,
and 20% PEG8000 and flash frozen at 100 K in a stream of nitrogen
gas. X-ray diffraction data were collected at 100 K on a MAR345 image plate using Cu K radiation ( = 1.5418 Å) from an in-house
Rigaku rotating anode x-ray generator operating at 48 kV and 98 mA. The crystals belonged to the space group P1, with unit cell
dimensions a = 62.47, b = 66.90, c = 95.54 Å, = 89.72o, = = 90o. A total of 285817 reflections were
measured, with an Rmerge of 7.9% for 74790 unique reflections and 95.8% completeness (50 - 2.2 Å). The
data were collected to 90.1% completeness in the highest resolution shell.
The structure was solved by molecular replacement, based on the crystal
structure of wild type CYP101 with bound camphor (Protein Data Bank
code 2CPP). In the crystal of the mutant, although the three angles of
the unit cell are all virtually 90°, the Rsys value for an orthorhombic system was considerably higher than that for
a monoclinic cell. More importantly, extensive molecular replacement
was attempted in all possible orthorhombic space groups without any
success. Hence, prior to soaking of the substrate, the mutant was
determined to be of the P21 space group where we were able to find two molecular replacement solutions corresponding to
the two molecules/asymmetric unit. The P21 space
group was also found in a similar study (29). However, when these
solutions were used for the complex structure resulting from the
soaking experiments, we were not able to refine the structure of the
complex in the P21 space group. After realizing
that a breakdown of symmetry may have occurred because of soaking and
entry of the substrate, we switched to the P1 space group
where we placed the additional two molecules in P1 via
P21 symmetry operations. As a result, the
refinement proceeded smoothly. No noncrystallographic symmetry constraints were applied to the four protein molecules in the P1 cell. As evident in the difference Fourier map, two
molecules (A and B) showed clear electron density above the heme group, which could be readily modeled as 1,3,5-TCB. Difference density in
molecule C was sufficiently strong to accommodate the substrate, although its orientation was somewhat ambiguous. In contrast, the
density near the heme group of the fourth molecule (D) was rather weak
and too small for 1,3,5-TCB to be fitted. Despite the fact that the
weak density could represent a weakly bound substrate with very low
occupancy, in the final structure it was more reasonable to model the
density as a cluster of three water molecules. The final refinement
parameters were Rwork = 18.6% and
Rfree = 25.8%. The data collection and
structure refinement statistics are summarized in Table I.
NADH Turnover Rate Determinations--
All of the incubations
were carried out at 30 °C. Incubation mixtures (1.7 ml) contained 50 mM Tris, pH 7.4, 200 mM KCl, 1 µM
CYP101, 10 µM putidaredoxin, 1 µM
putidaredoxin reductase, and 30 µg ml 1 bovine catalase
(30). The mixtures were oxygenated and then equilibrated at 30 °C
for 2 min. The PeCB and HCB substrates were added as 10 mM
stocks in Me2SO to a nominal final concentration in an
incubation mixture of 100 µM. Precipitation of both
substrates was observed. NADH was added to ~160 µM
(final A340 = 1.00), and the absorbance at
340 nm was monitored. In the case of the F87W/Y96F/L244A/V247L mutant,
the absorbance at 340 nm did not drop to 0 because the mutant produced
appreciable amounts of the PCP product, which had an absorption maximum
at 325 nm. However, this did not interfere with the determination of
the rate of NADH consumption, which was calculated from the slope of
the time-course plot using 340 = 6.22 mM 1 cm 1. The maximum
concentration of Me2SO in an incubation reaction was 0.2%
(v/v), and control experiments showed that Me2SO at 2% (v/v) did not induce any changes in the heme spin state equilibrium nor
increases in the rate of NADH consumption.
Metabolite Assays--
After all of the NADH had been consumed
in an incubation reaction, 2-naphthol was added to the mixture to act
as an internal standard for the solid phase extraction and HPLC
analysis steps. Organics in the mixtures were adsorbed onto a Varian
Bond-Elut C18 column (1 ml of matrix volume) that had been
equilibrated by washing with 1 ml of methanol followed by 1 ml of 50 mM Tris, pH 7.4. The column was then washed with 1 ml of 50 mM Tris, pH 7.4, and dried under vacuum for 5 min. The
bound organics were eluted with 1 ml of acetonitrile.
The polychlorinated benzenes and their metabolites were separated by
reverse phase HPLC using acetonitrile/water, pH 3.0, gradients
developed on a C18 column (2.5 mm inner diameter × 250 mm). The flow rate was 1 ml min 1, and the eluent was
monitored at 220 nm. A 450-µl aliquot of the acetonitrile eluent from
the Bond-Elut column was mixed with 550 µl of water, pH 3.0, and 100 µl of the mixture (45% v/v acetonitrile in water) was injected onto
the column. The acetonitrile concentration was increased from 45 to
75% over 10 min and then maintained at 75% for 8 min. The retention
time of the PCP product was 16.5 min.
The PCP concentration in incubation mixtures was calculated by
calibrating the concentration response of the HPLC detector to this
compound. Mixtures containing different concentrations of PCP and all
of the components of a normal incubation, except NADH and substrate,
were extracted and analyzed as for normal incubations. The plot of the
ratio of the peak area for PCP to the 2-naphthol internal standard
against the PCP concentration gave a calibration plot from which the
absolute concentration of PCP produced by enzymatic turnover in an
incubation mixture could be determined. The coupling efficiency was the
percentage of NADH consumed that lead to PCP formation.
We found that the results of PCP analysis were more variable than for
the less chlorinated analogues we had studied earlier (20, 21). This
was true even for the calibration experiments carried out at different
times, and the variations increased with increasing PCP concentration.
The problem was particularly acute for the F87W/Y96F/L244A/V247L
mutant, which had the highest coupling efficiency, with some early
analyses indicating erroneously high couplings. The reasons for the
variability were not clear, but consistent results were eventually
obtained by carrying out calibration controls in parallel with
incubation assays at concentrations above and below the PCP
concentration expected from enzymatic substrate oxidation.
 |
RESULTS AND DISCUSSION |
The Structure of the F87W/Y96F/V247L Mutant
with 1,3,5-TCB Bound--
The CYP101 mutant F87W/Y96F/V247L was
crystallized from cacodylate buffer and PEG8000. Soaking the crystals
in the well solution with 100 µM 1,3,5-TCB added did not
give good quality crystals. The conditions were varied, and we found
that soaking in MES buffer for 5 days gave the best results. Longer
soak times resulted in deterioration of the crystals and lower data
resolution. The crystals of the F87W/Y96F/V247L mutant with 1,3,5-TCB
bound in the active site diffracted to beyond 2.0 Å resolution, and
the structure at 2.2 Å resolution was solved by molecular replacement
methods. There were four protein molecules (A, B, C, and D) in the unit cell, three of which (A, B, and C) contained the 1,3,5-TCB substrate within the active site, whereas only water molecules were modeled in
the substrate pocket in molecule D. The 1,3,5-TCB substrate was bound
in different orientations in molecules A, B, and C.
We also obtained another crystal form under similar crystallization
conditions. These crystals belonged to the space group P21, with two enzyme molecules in each unit
cell. One molecule was the substrate-free form, whereas the other had a
1,3,5-TCB substrate bound in a very similar orientation to that found
in molecule A of the monoclinic crystals. However, this
P21 form diffracted only to 2.5 Å resolution,
and further refinement was not pursued.
General Structural Features--
The electron density of the first
9 amino acid residues was not observed in any of the four molecules in
the unit cell, otherwise the mutant retained all of the structural
features of the wild type (31). Some general structural parameters for
the mutant molecules are compared with those for the wild type in Table
I. The C backbones of all four
molecules were almost superimposable on that of the wild type. The heme
was ruffled, and the iron atom was out of the porphyrin ring and toward
the sulfur of the proximal cysteine. Potassium was found at the
proposed cation-binding site near the protein surface on the distal
side of the heme (31). Protein-heme contacts such as those between the
side chains of Arg112, His355, and
Asp297, and the heme propionate groups were present.
The Thr101 side chain in our monoclinic crystals was
rotated by ~90o compared with the orthorhombic crystal
form of the wild type (31), with the OH group forming a hydrogen bond
with the propionate group of pyrrole D. This change in side chain
orientation had been observed previously in the structure of a
similarly monoclinic form of the wild type crystallized from Tris
buffer and PEG4000 (29). However, in both monoclinic forms there was
little effect on the conformation of other side chains.
The planes of the aromatic side chains at the 87 and 96 positions in
the wild type and all four molecules of the mutant were virtually
superimposable, although the main chain and side chain of the 87 residue were shifted by ~0.4 Å. Similar slight shifts were also
observed for the 247 residue. The Phe98 phenyl ring was
rotated by ~20o in all four molecules, apparently to
avoid steric hindrance between Phe98 CE and
Leu247 CD. The indole NH group of Trp87
pointed toward the heme, whereas the benzene ring was oriented toward
the Leu247 side chain. The orientation of the geminal
methyl groups of Leu247 varied slightly in the four protein
molecules, but in all cases the closest distance between the
Trp87 and Leu247 side chains was 4.0-4.3 Å,
compared with 6.5 Å between Phe87 and Val247
in the wild type. It is evident that the three mutations had only minor
effects on the structure of CYP101.
Poulos et al. (31) noted previously that the structure of
CYP101 does not show an obvious substrate access channel, and dynamic
fluctuations are required to allow entry of a potential substrate. The
close position of the Trp87 and Leu247 side
chains at the top of the CYP101 active site indicates that the
structural fluctuations are sufficient to move both of these sterically
demanding side chains out of the way, such that an incoming substrate,
e.g. 1,3,5-TCB, can enter and bind in the active site.
1,3,5-TCB Binding in Molecule A--
The active site structure of
molecule A with 1,3,5-TCB bound, together with the electron density for
the substrate, is shown in Fig. 2. (The
contact distances between 1,3,5-TCB and the heme and protein side
chains are detailed in the supplemental table. There were no water
molecules in the active site.) The substrate was located mainly over
pyrroles A and D and the meso carbons CHA and CHB. The C-4
atom of 1,3,5-TCB was at a distance of 4.01 Å above the heme iron with
a C/Fe/S (Cys357) angle of 170°, compared with 4.21 Å and 164° for camphor C-5 in the wild type structure. The angle
between the 1,3,5-TCB plane and the porphyrin was 28°, and these two
aromatic systems were in van der Waals' contact.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 2.
A stereo view of the active site structure of
molecule A in the unit cell, with some active site residues omitted for
clarity. The electron density (in blue) above the heme
was fitted by the 1,3,5-TCB substrate. The 1,3,5-TCB chlorine
atoms are in green, with Cl-1 beneath the Phe87
indole side chain, whereas Cl-3 contacted Leu244, and Cl-5
was close to Val295. The figure was generated with
BOBSCRIPT and MOLSCRIPT and rendered by RASTER3D.
|
|
The heme and 1,3,5-TCB chlorine atoms played very important roles in
the enzyme-substrate interactions. There was strong van der Waals'
interaction between Cl-3 and pyrrole D. Cl-5 was close to the
meso carbon CHB, and it also contacted the
Val295 side chain (Fig. 3).
Both Cl-3 and C-2 contacted the Leu244 side chain, and Cl-3
also contacted the backbone of Gly248. The Cl-1 atom was
3.00 Å away from the indole nitrogen of Trp87, indicating
a hydrogen bonding interaction. This chlorine atom was also within
hydrogen bonding distance (3.40 Å) of a carboxylate oxygen of
Asp297. The hydrogen bond to the indole NH of
Trp87 appeared to pull the Cl-1/C-1 end of the 1,3,5-TCB
molecule slightly upwards and tilt the plane of the ring away from
being parallel to the porphyrin.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
Details of 1,3,5-TCB binding in molecule A
showing the location of the 1,3,5-TCB substrate above the heme, with
Cl-1 directly beneath Trp87, Cl-3 over pyrrole D and Cl-5
over the heme meso carbon CHB. The C-2 and Cl-3
atoms of 1,3,5-TCB contacted Leu244 (van der Waals'
surface shown), and Cl-5 contacted Val295. The C-4 atom is
located directly above the heme iron. The figure was generated with the
program Weblab Viewerpro.
|
|
The substrate binding orientation in molecule A, with the benzene ring
almost parallel to and in van der Waals' contact with the porphyrin
ring might be considered to be very favorable for both 1,3,5-TCB
binding and oxidation. The substrate is close to the heme, preventing
access of water to the iron atom during the catalytic cycle. The
substrate C-4 atom is poised over the iron atom, at a comparable
distance to camphor C-5 in the wild type, and so efficient attack by
the ferryl intermediate is expected. The predicted product would be
2,4,6-trichlorophenol, as observed experimentally.
1,3,5-TCB Binding in Molecule B--
The 1,3,5-TCB binding
orientation in molecule B and the electron density for the substrate
are shown in Fig. 4. As observed with
molecule A, there were no water molecules in the active site. The
substrate binding orientation in molecule B was related to that in
molecule A by a tilt of the plane of the benzene about the C-4 atom,
increasing the angle between the ring and the porphyrin from 28 to
66°. The Cl-3, C-4, and Cl-5 atoms remained over pyrrole D and the
CHB meso carbon, but all three atoms moved closer to the
heme, resulting in more substrate/heme contacts. The Cl-1 atom moved
away from the pyrrole NH (3.80 Å versus 3.04 Å) and toward
the benzene CZ2 and CH2 atoms of the Trp87 indole side
chain and into contact with CG of the Leu247 side chain.
The ring tilt also brought C-2 away from Leu244 and into
contact with Leu247, whereas C-6 moved away from
Val295 and came into contact with the Val396
side chain.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 4.
A stereo view of the active site structure of
molecule B in the unit cell, with some active site residues omitted for
clarity. The electron density (in blue) above the heme
was fitted by the 1,3,5-TCB substrate, with the chlorine atoms in
green. The angle between the planes of the substrate ring
and the porphyrin is 66°, compared with 28° in molecule A. Compared
with molecule A, the Cl-3 and Cl-5 atoms remained close to the heme,
and the substrate plane is tilted about the C-4 atom such that Cl-1
moved away from the Trp87 indole NH toward the indole
benzene ring and also approaches Leu247. The figure was
generated with BOBSCRIPT and MOLSCRIPT and rendered by RASTER3D.
|
|
The C-4 atom of 1,3,5-TCB was 3.40 Å from the heme iron, with a
C-4/Fe/S (Cys357) angle of 163°. The predicted substrate
oxidation product for the binding orientation in molecule B would be
2,4,6-trichlorophenol, in agreement with the experiment.
1,3,5-TCB Binding in Molecule C--
We had great difficulty in
fitting a unique substrate binding orientation to the electron density
above the heme in molecule C. Interestingly, all of the orientations
that fitted the density reasonably well contained a close distance
(<3.2 Å) between a substrate chlorine atom and the heme iron,
suggesting a bonding interaction. However, all of these orientations
also contained one or more very short enzyme/substrate contacts. We
believe that the most reasonable interpretations of the data are that
(a) there is direct bonding interaction between a chlorine
lone pair of electrons and the heme iron and (b) there are a
number of closely related and perhaps interconverting 1,3,5-TCB binding
orientations such that the electron density is smeared out and the fit
to individual orientations is poor. Direct interaction between the heme
iron and a lone pair on an exogenous organic molecule has been reported in the crystal structure of wild type CYP101 with
5-exo-hydroxycamphor bound, in which the hydroxyl group is
directly bonded to the iron center (32).
There are a number of common features in the different potential
1,3,5-TCB binding orientations in molecule C. All of the orientations
could be considered to be derived from that in molecule B by further
tilting about C-4 and rotation about the Cl-1/C-1/C-4 vector. There are
additional movements so that the Cl-3 atom is at different distances
from the heme iron and the Cl-3/Fe/S (Cys357) angles also
varied. One orientation is shown in Fig.
5. The distance between Cl-3 and the heme
iron was 3.2 Å, which was the longest Fe-Cl distance among all of the
orientations. There was one particularly short contact (2.6 Å) between
Cl-5 and the porphyrin atom ND. The Cl-1 atom moved further away from
the indole NH compared with the substrate in molecule B, so that it
pointed into the gap between the Trp87 and
Leu247 side chains. The angle between the substrate benzene
ring and the porphyrin was increased to 115° from 66° in molecule
B.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
A stereo view of the active site structure of
molecule C in the unit cell, with some residues omitted for
clarity. No unique fit of 1,3,5-TCB to the electron density was
possible. The shape of the density strongly suggest that the Cl-1 atom
is below and between the Trp87 and Leu247 side
chains, but the positions of the Cl-3 and Cl-5 atoms are poorly
defined, although Cl-3 appears to be close to the heme iron. The
possible fit to the density shown has a Fe-Cl distance of 3.2 Å. The
other potential fits have shorter Fe-Cl distances, but all of the fits
suffer the problem of one or more very short (<2.5 Å) substrate-heme
contacts. See text for further discussion. The figure was generated
with BOBSCRIPT and MOLSCRIPT and rendered by RASTER3D.
|
|
Because the Fe-Cl bond must be broken for dioxygen binding to occur,
the modeled substrate binding orientations in molecule C did not allow
the direct prediction of the product formed. However, it might be
presumed that once the bond is broken the substrate might assume
orientation(s) similar to that in molecule B, and 2,4,6-trichlorophenol
would be the product.
Molecule D--
The electron density above the heme in molecule D
could not be fitted to 1,3,5-TCB at full occupancy, and the fit was
only marginally better at lower occupancy values. We therefore modeled the density with a cluster of three hydrogen-bonded water molecules. However, there are too many uncertainties, even in this model, for any
detailed inferences to be drawn from the structure.
Implications in CYP101 Activity and Further Protein
Engineering--
The present crystal structure offered a framework for
rationalizing the role of different active site residues in the binding and oxidation of 1,3,5-TCB by CYP101 (Table
II). We suggested previously that the
Y96F mutation most likely promoted the binding of hydrophobic organic
compounds by increasing the active site hydrophobicity (20,
33-37).
View this table:
[in this window]
[in a new window]
|
Table II
The catalytic parameters for the oxidation of 1,3,5-trichlorobenzene,
pentachlorobenzene, and hexachlorobenzene by wild-type and mutants
of CYP101
The data are the means of at least three experiments, with all data for
each parameter being within 15% of the mean. % HS (± 5%) is the
high spin heme content in the presence of excess substrate. N is the
NADH turnover rate, k2 is the product formation rate
(2,4,6-TCP for 1,3,5-TCB; PCP for PeCB and HCB), and both rates are
given in nmol (nmol CYP101) 1 min 1. ND, no product
observed; , not determined.
|
|
We found that introducing the F87W mutation increased both the NADH
turnover rate and coupling for 1,3,5-TCB oxidation by more than
10-fold. Adding the V247L mutation increased the NADH turnover rate
further, but there was little effect on the coupling. Close examination
of the structure of the wild type and the F87W/Y96F/V247L triple mutant
complex suggested a plausible explanation. In the wild type structure
there was a "pocket" near the top of the active site. This pocket,
6-6.5 Å across, was defined by the side chains of the residues at
positions 87, 96, 98, 185, and 247 and capped on the top by
Met184 and Phe193 (Fig.
6). Although too small to accommodate the
entire 1,3,5-TCB molecule, it was sufficiently large to bind part of it
(e.g. one of the chlorine atoms and one or more ring
carbons) so that on average the 1,3,5-TCB substrate could be located
further away from the heme. Consequently 1,3,5-TCB oxidation by the
wild type would be slow and extensively uncoupled.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 6.
The hydrophobic pocket at the top of the
active site in the wild type structure. The pocket is defined by
the side chains of the residues at the 87, 96, 98, 185, and 247 positions and capped on the top by Met184 and
Phe193. The cavity in the center is ~6.5 Å across at the
narrowest part, which is reduced to 4-4.3 Å in the F98W/Y96F/V247L
mutant. The figure was generated with the program Weblab
viewerpro.
|
|
In the structure of the F87W/Y96F/V247L mutant complex, the
Trp87 indole side chain pointed toward the
Leu247 butyl group, and these two side chains approached
each other to within 4.3 Å, compared with 6.5 Å between
Phe87 and Val247 in the wild type structure.
The pocket in the mutant was therefore much smaller and, in a static
picture at least, effectively closed to substrate binding. This should
constrain the 1,3,5-TCB to bind closer to the heme, thus increasing the
NADH turnover rate and coupling (21, 23). The F87W mutation on its own
would be less effective in closing down this pocket, hence the slightly
lower activity of the F87W/Y96F mutant. The increase in high spin heme content (see Table II), in particular from the Y96F mutant to the
F87W/Y96F double mutant, is consistent with this argument. We note that
the presence of a direct Fe-Cl interaction in molecule C would explain
the incomplete conversion of the heme in the F87W/Y96F/V247L mutant to
the high spin form upon 1,3,5-TCB binding at 30 °C, even though the
structure showed that there were no water molecules in the active site.
The observed substrate binding orientation in molecules A and B
correctly predicted the product of 1,3,5-TCB oxidation. As discussed
earlier the potential binding orientations in molecule C could also
lead to 2,4,6-trichlorophenol as the only product. The effective
exclusion of water and the close approach of a C-H bond to the heme
iron in molecules A and B were consistent with the high coupling
efficiency (57%) for the F87W/Y96F/V247L triple mutant (20, 21). It
was notable, however, that the coupling was not the >95% observed for
camphor oxidation by the wild type, even though there was no water in
the active site, and the 1,3,5-TCB substrate was poised over the heme
for attack by the ferryl intermediate. The crystal structure revealed a
number of possible factors. First, multiple substrate binding
orientations were observed, even at 100 K. It is likely that at
ambient temperature the 1,3,5-TCB substrate has some mobility. As noted
by Raag and Poulos (38), mobility of a substrate in the active site,
for example in the form of interconversion between the orientations in
molecule B and C by substrate rotation, could interfere with the
iron-dioxygen interaction and lead to uncoupling.
The 1,3,5-TCB binding orientation in molecule B may also be
significant. The crystal structure, which is a static picture, showed
that the Trp87 and Leu247 side chains appeared
to act as a set of "double lids" to close off the top of the active
site. However, these side chains also had to move out of the way,
probably as a result of the normal dynamic structural fluctuations of
the protein, to allow the substrate to enter the active site. These
fluctuations could also allow 1,3,5-TCB in molecule B to move into the
pocket at the top of the active site and away from the heme for some of
the time. Consequently, the coupling efficiency would be reduced. In
this context we note that all of the potential substrate binding
orientations in molecule C had the substrate Cl-1 atom just beneath the
Trp87 and Leu247 side chains. Once the Fe-Cl
bond is broken, the same uncoupling mechanism could also come into
operation. We therefore believe that the orientation in molecule A is
probably the most "productive," whereas those in B and C could lead
to uncoupling.
The 1,3,5-TCB binding orientation and enzyme-substrate contacts
suggested a strategy and other mutations that could enhance the
activity of CYP101 for the oxidation of the highly recalcitrant, heavily chlorinated benzenes. Our earlier work showed that the F87W/Y96F/V247L mutant had a fast NADH turnover rate but poor coupling
for PeCB oxidation. We therefore sought further mutations that could
promote PeCB binding in the orientation observed for 1,3,5-TCB in
molecule A. Viewing the structure from above the active site, the
Leu244 side chain fitted neatly between Cl-1 and Cl-3 of
1,3,5-TCB (Fig. 3). There was no space to accommodate the extra
chlorine atom in PeCB or HCB. These two substrates could not be bound
in the near-parallel orientation and consequently the coupling
efficiencies were low. One solution would be to introduce the L244A
mutation (39-41) to create space to promote PeCB and HCB binding in
this orientation. We therefore prepared the new mutants
F87W/Y96F/L244A, F87W/Y96F/V247A, and F87W/Y96F/L244A/V247L to examine
the effect of mutations at the 244 and 247 positions on the PeCB and
HCB oxidation activity of CYP101.
Polychlorinated Benzene Oxidation Activity of CYP101
Mutants--
The rates of NADH turnover and product formation and the
derived coupling efficiencies for PeCB and HCB oxidation by the CYP101 enzymes are given in Table II. Wild type CYP101 showed slow but detectable NADH turnover activity with these two substrates, but no
products were observed, whereas all of the mutants oxidized both PeCB
and HCB to PCP.
Considering the PeCB data first, the results showed that the crystal
structure-based protein engineering approach was successful. The
F87W/Y96F/L244A/V247L mutant oxidized PeCB at a rate of 82.5 min 1 and with 24% coupling efficiency. This substrate
oxidation activity was 45 times higher than the parent F87W/Y96F/V247L
mutant, and the most significant factor was the 10-fold increase in the
coupling (Table II). The importance of both the L244A and V247L
mutations was clearly demonstrated by comparison between the activities of the F87W/Y96F/V247L, F87W/Y96F/V247A, and F87W/Y96F/L244A mutants. The V247A mutation was expected to open up the pocket at the top of the
active site (Fig. 6), PeCB could bind away from the heme, hence both
the activity and coupling of the F87W/Y96F/V247A mutant were very low.
The L244A mutation, on the other hand, could create the space necessary
for PeCB to adopt the apparently favorable binding orientation observed
for 1,3,5-TCB in molecule A. The high spin heme content was increased,
and the coupling of the F87W/Y96F/L244A mutant was 10-fold higher than
those for the F87W/Y96F and F87W/Y96F/V247L mutants. However, the L244A
mutation on its own was not sufficient to induce a very high proportion
of PeCB molecules to bind closer to the heme, hence the small effect on the NADH turnover rate. It is interesting that combining the "pull" of the L244A mutation with the "push" of the V247L increased the high spin heme content and enabled the enzyme to have both fast NADH
turnover activity and reasonable coupling efficiency for PeCB oxidation.
In general terms the activity trends for HCB oxidation mirrored those
for PeCB. The F87W/Y96F/L244A/V247L mutant was again the most active
(200 times faster than the F87W/Y96F/V247L mutant), but both the
activity and coupling were much lower than for PeCB. The lower
solubility and chemical reactivity of HCB compared with PeCB might be
significant factors. It should be noted, however, that the PeCB and HCB
oxidation rates cannot be compared directly, because the conversion of
HCB to PCP by oxidative dechlorination required four electrons from two
molecules of NADH. The likely mechanism of this reaction proceeds via
an arene oxide or a ketone intermediate generated by an NIH
shift step involving chlorine (Scheme 1).
Such a shift has been observed recently in the flavin monooxygenase-mediated oxidation of benzene compounds (42). Reduction
by two electrons, loss of chloride, and protonation gives the PCP
product.
The extra complication with HCB was that the reduction steps in Scheme
1 might be slow but tightly coupled, whereas the initial oxidative
attack could have a faster NADH oxidation rate but low coupling. We
have no evidence to determine whether the rate-limiting step was the
first electron transfer to initiate the CYP101 catalytic cycle for the
oxidation of HCB or the electron transfer from the ferrous heme to the
proposed arene oxide/ketone intermediate to expel the chloride ion.
Nevertheless, both of these reactions were expected to be faster if the
substrate was bound close to the heme, hence the higher activity of the
F87W/Y96F/L244A/V247L mutant.
Summary and Conclusions--
The crystal structure of the CYP101
active site mutant F87W/Y96F/V247L with 1,3,5-TCB bound has been
determined, providing new insights into substrate recognition by CYP101
and the basis for rationalizing the NADH consumption rate and coupling
efficiency. Multiple 1,3,5-TCB binding orientations were observed. One
such orientation, with the benzene ring being almost parallel to and in
van der Waals' contact with the heme is likely to be the most favorable for faster and more tightly coupled substrate oxidation. By
examining the enzyme-substrate contacts, we designed and prepared the
F87W/Y96F/L244A/V247L mutant and showed that it had significantly increased activity for the oxidation of the most heavily chlorinated benzenes PeCB and HCB. The observed activities are sufficient for the
application of this quadruple mutant in the effective bioremediation of
PeCB and HCB. The success of the combined approach of crystal structure
determination and further rational redesign suggests that the oxidation
of other environmental contaminants by engineered CYP101 and other
cytochrome P-450 enzymes and the subsequent degradation of their
metabolites, may also be possible.
 |
ACKNOWLEDGEMENTS |
We are grateful to Yixin Sun and Rong Cao for
technical assistance and to Feng Gao for assistance with data collection.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1J51) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
The on-line version of this article (available at
http://www.jbc.org) contains a supplemental table and diagram.
¶
Supported by National Science Foundation of China Grants
39970155, 2001AA23301 (Project 863), G1999075602 (Project 973),
G1999011902, and 1998051105. To whom correspondence may be addressed.
Tel.: 86-10-6277-1493; Fax: 86-10-6277-3145; E-mail:
raozh@xtal.tsinghua.edu.cn.
Supported by United Kingdeom Biotechnology and Biological
Sciences Research Council Grant E12155 and by the Higher Education Funding Council for England. To whom correspondence may be addressed. Tel.: 44-1865-275963; Fax: 44-1865-272690; E-mail:
luet.wong@chem.ox.ac.uk.
Published, JBC Papers in Press, July 11, 2002, DOI 10.1074/jbc.M203762200
 |
ABBREVIATIONS |
The abbreviations used are:
PeCB, pentachlorobenzene;
TCB, trichlorobenzene;
HCB, hexachlorobenzene;
PCP, pentachlorophenol;
HPLC, high pressure liquid chromatography;
MES, 4-morpholineethanesulfonic acid.
 |
REFERENCES |
| 1.
|
Guengerich, F. P.
(1991)
J. Biol. Chem.
266,
10019-10022[Free Full Text]
|
| 2.
|
Ortiz de Montellano, P. R.
(ed)
(1995)
Cytochrome P450: Structure, Mechanism, and Biochemistry
, 2nd Ed.
, Plenum Press, New York
|
| 3.
|
Kellner, D. G.,
Maves, S. A.,
and Sligar, S. G.
(1997)
Curr. Opin. Biotechnol.
8,
274-278[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Wong, L. L.
(1998)
Curr. Opin. Chem. Biol.
2,
263-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Miles, C. S.,
Ost, T. W.,
Noble, M. A.,
Munro, A. W.,
and Chapman, S. K.
(2000)
Biochim. Biophys. Acta
1543,
383-407[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Robinson, G. K.,
and Lenn, M. J.
(1994)
Biotechnol. Genet. Eng. Rev.
12,
139-188[Medline]
[Order article via Infotrieve]
|
| 7.
|
Fetzner, S.,
and Lingens, F.
(1994)
Microbiol. Rev.
58,
641-685[Abstract/Free Full Text]
|
| 8.
|
Beil, S.,
Happe, B.,
Timmis, K. N.,
and Pieper, D. H.
(1997)
Eur. J. Biochem.
247,
190-199[Medline]
[Order article via Infotrieve]
|
| 9.
|
Potrawfke, T.,
Timmis, K. N.,
and Wittich, R. M.
(1998)
Appl. Environ. Microbiol.
64,
3798-3806[Abstract/Free Full Text]
|
| 10.
|
Haigler, B. E.,
Nishino, S. F.,
and Spain, J. C.
(1988)
Appl. Environ. Microbiol.
54,
294-301[Abstract/Free Full Text]
|
| 11.
|
Neilson, A. H.
(1996)
Int. Biodeter. Biodeg.
38,
3-21
|
| 12.
|
Marinucci, A. C.,
and Bartha, R.
(1979)
Appl. Environ. Microbiol.
38,
811-817[Abstract/Free Full Text]
|
| 13.
|
Broderick, J. B.,
and O'Halloran, T.
(1991)
Biochemistry
30,
7349-7358[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Feidieker, D.,
Kaempfer, P.,
and Dott, W.
(1994)
FEMS Mic. Ec.
15,
265-278
|
| 15.
|
Solyanikova, I. P.,
and Golovleva, L. A.
(1999)
Biochemistry
64,
365-372[Medline]
[Order article via Infotrieve]
|
| 16.
|
Orser, C. S.,
and Lange, C. C.
(1994)
Biodegradation
5,
277-288[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Lee, S. G.,
Yoon, B. D.,
Park, Y. H.,
and Oh, H. M.
(1998)
J. Appl. Microbiol.
85,
1-8[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Leung, K. T.,
Cassidy, M. B.,
Shaw, K. W.,
Lee, H.,
Trevors, J. T.,
Lohnmeier Vogel, E. M.,
and Vogel, H. J.
(1997)
World J. Microbiol. Biotechnol.
13,
305-313[CrossRef]
|
| 19.
|
Radehaus, P. M.,
and Schmidt, S. K.
(1992)
Appl. Environ. Microbiol.
58,
2879-2885[Abstract/Free Full Text]
|
| 20.
| Jones, J. P., O'Hare, E. J., and Wong, L. L. (2000)
Chem. Commun. 247-248
|
| 21.
|
Jones, J. P.,
O'Hare, E. J.,
and Wong, L. L.
(2001)
Eur. J. Biochem.
268,
1460-1467[Medline]
[Order article via Infotrieve]
|
| 22.
|
Gunsalus, I. C.,
and Wagner, G. C.
(1978)
Methods Enzymol.
52,
166-188[Medline]
[Order article via Infotrieve]
|
| 23.
|
Mueller, E. J.,
Loida, P. J.,
and Sligar, S. G.
(1995)
in
Cytochrome P450: Structure, Mechanism, and Biochemistry
(Ortiz de Montellano, P. R., ed), 2nd Ed.
, pp. 83-124, Plenum Press, New York
|
| 24.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 25.
|
Westlake, A. C.,
Harford-Cross, C. F.,
Donovan, J.,
and Wong, L. L.
(1999)
Eur. J. Biochem.
265,
929-935[Medline]
[Order article via Infotrieve]
|
| 26.
|
Peterson, J. A.,
Lorence, M. C.,
and Amarneh, B.
(1990)
J. Biol. Chem.
265,
6066-6073[Abstract/Free Full Text]
|
| 27.
|
Yasukochi, T.,
Okada, O.,
Hara, T.,
Sagara, Y.,
Sekimizu, K.,
and Horiuchi, T.
(1994)
Biochim. Biophys. Acta
1204,
84-90[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Nickerson, D. P.,
and Wong, L.-L.
(1997)
Prot. Engng.
10,
1357-1361[Abstract/Free Full Text]
|
| 29.
|
Schlichting, I.,
Berendzen, J.,
Chu, K.,
Stock, A. M.,
Maves, S. A.,
Benson, D. E.,
Sweet, R. M.,
Ringe, D.,
Petsko, G. A.,
and Sligar, S. G.
(2000)
Science
287,
1615-1622[Abstract/Free Full Text]
|
| 30.
|
Stevenson, J.-A.,
Westlake, A. C. G.,
Whittock, C.,
and Wong, L.-L.
(1996)
J. Am. Chem. Soc.
118,
12846-12847[CrossRef]
|
| 31.
|
Poulos, T. L.,
Finzel, B. C.,
and Howard, A. J.
(1987)
J. Mol. Biol.
195,
687-700[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Li, H.,
Narasimhulu, S.,
Havran, L. M.,
Winkler, J. D.,
and Poulos, T. L.
(1995)
J. Am. Chem. Soc.
117,
6297-6299[CrossRef]
|
| 33.
|
Bell, S. G.,
Rouch, D. A.,
and Wong, L. L.
(1997)
J. Mol. Catal. B Enzym.
3,
293-302
|
| 34.
|
Nickerson, D. P.,
Harford-Cross, C. F.,
Fulcher, S. R.,
and Wong, L. L.
(1997)
FEBS Lett.
405,
153-156[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
England, P. A.,
Harford-Cross, C. F.,
Stevenson, J. A.,
Rouch, D. A.,
and Wong, L. L.
(1998)
FEBS Lett.
424,
271-274[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Harford-Cross, C. F.,
Carmichael, A. B.,
Allan, F. K.,
England, P. A.,
Rouch, D. A.,
and Wong, L.-L.
(2000)
Protein Eng.
13,
121-128[Abstract/Free Full Text]
|
| 37.
| Stevenson, J.-A., Bearpark, J. K., and Wong, L.-L. (1998)
New J. Chem. 551-552
|
| 38.
|
Raag, R.,
and Poulos, T. L.
(1991)
Biochemistry
30,
2674-2684[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
De Voss, J. J.,
and Ortiz de Montellano, P. R.
(1995)
J. Am. Chem. Soc.
117,
4185-4186[CrossRef]
|
| 40.
|
De Voss, J. J.,
Sibbesen, O.,
Zhang, Z. P.,
and Ortiz de Montellano, P. R.
(1997)
J. Am. Chem. Soc.
119,
5489-5498[CrossRef]
|
| 41.
|
French, K. J.,
Rock, D. A.,
Manchester, J. I.,
Goldstein, B. M.,
and Jones, J. P.
(2002)
Arch. Biochem. Biophys.
398,
188-197[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Hartmann, S.,
Hultschig, C.,
Eisenreich, W.,
Fuchs, G.,
Bacher, A.,
and Ghisla, S.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7831-7836[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Takagi, A. Iwasaki, I. Kamei, K. Satsuma, Y. Yoshioka, and N. Harada
Aerobic Mineralization of Hexachlorobenzene by Newly Isolated Pentachloronitrobenzene-Degrading Nocardioides sp. Strain PD653
Appl. Envir. Microbiol.,
July 1, 2009;
75(13):
4452 - 4458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Xu, S. G. Bell, Z. Rao, and L.-L. Wong
Structure-activity correlations in pentachlorobenzene oxidation by engineered cytochrome P450cam
Protein Eng. Des. Sel.,
October 24, 2007;
(2007)
gzm028v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D.-Z. Yan, H. Liu, and N.-Y. Zhou
Conversion of Sphingobium chlorophenolicum ATCC 39723 to a Hexachlorobenzene Degrader by Metabolic Engineering.
Appl. Envir. Microbiol.,
March 1, 2006;
72(3):
2283 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|